SLC25A20 Antibody - C-terminal region
Artikelnummer:
ASB-ARP43748_P050
- Bilder (4)
| Artikelname: | SLC25A20 Antibody - C-terminal region |
| Artikelnummer: | ASB-ARP43748_P050 |
| Hersteller Artikelnummer: | ARP43748_P050 |
| Alternativnummer: | ASB-ARP43748_P050-25UL,ASB-ARP43748_P050-100UL |
| Hersteller: | Aviva |
| Wirt: | Rabbit |
| Kategorie: | Proteine/Peptide |
| Applikation: | WB |
| Spezies Reaktivität: | Bovine, Canine, Equine, Guinea pig, Human, Mouse, Rabbit, Rat, Sheep, Zebrafish |
| Immunogen: | The immunogen is a synthetic peptide directed towards the C terminal region of human SLC25A20 |
| Alternative Synonym: | CAC, CACT |
| SLC25A20 is one of several closely related mitochondrial-membrane carrier proteins that shuttle substrates between cytosol and the intramitochondrial matrix space.It mediates the transport of acylcarnitines into mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. Mutations in this gene are associated with carnitine-acylcarnitine translocase deficiency, which can cause a variety of pathological conditions such as hypoglycemia, cardiac arrest, hepatomegaly, hepatic dysfunction and muscle weakness, and is usually lethal in new born and infants.This gene product is one of several closely related mitochondrial-membrane carrier proteins that shuttle substrates between cytosol and the intramitochondrial matrix space. This protein mediates the transport of acylcarnitines into mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. Mutations in this gene are associated with carnitine-acylcarnitine translocase deficiency, which can cause a variety of pathological conditions such as hypoglycemia, cardiac arrest, hepatomegaly, hepatic dysfunction and muscle weakness, and is usually lethal in new born and infants. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. |
|
|
25 ug of the indicated Human whole cell extracts was loaded onto a 12% SDS-PAGE gel. 1 ug/mL of the antibody was used in this experiment. |
|
|
WB Suggested Anti-SLC25A20 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:312500 Positive Control: Jurkat cell lysateSLC25A20 is supported by BioGPS gene expression data to be expressed in Jurkat |
|
|
Host: Rabbit Target: SLC25A20 Positive control (+): Human liver (LI) Negative control (-): Human brain (BR) Antibody concentration: 1ug/ml |
|
|
SLC25A20 antibody - C-terminal region (ARP43748_P050) in Human Jurkat using Western Blot |
Produktgarantie und fachkundiger Support
